Endocrinology, diabetes & metabolism

Heart and blood vessel outcomes of GLP-1 medicines compared to weight loss surgery

Updated

Abstract

The network meta-analysis compares the cardiovascular effects of bariatric surgery and glucagon-like peptide-1 receptor agonists in individuals with obesity.

  • Obesity is linked to an increased risk of cardiovascular diseases, including heart failure and myocardial infarction.
  • Bariatric surgery and glucagon-like peptide-1 receptor agonists are both potential interventions for individuals with obesity.
  • This analysis integrates both direct and indirect evidence to evaluate the cardiovascular efficacy of these treatments.
  • Findings may inform healthcare decisions regarding the management of obesity-related cardiovascular risks.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free